VC-Backed Biotech Co. Leads 2 IPO Launches Totaling $139M
Venture capital-backed biotechnology firm Replimune Group Inc. launched an initial public offering estimated to raise about $101 million on Tuesday, joined by a Washington state community bank planning a $38 million...To view the full article, register now.
Already a subscriber? Click here to view full article